Brightree’s Mellott named Best MedTech CEO
By HME News Staff
Updated 8:41 AM CDT, Fri May 6, 2022
PEACHTREE, Ga. – Brightree CEO Matt Mellott has been named Best MedTech CEO in the 2022 MedTech Breakthrough Awards. The award is given to individuals who have made significant contributions to the global health and medical technology market. As Brightree CEO, Mellott has overseen a revamp of Brightree’s product team, and spearheaded development and execution of a comprehensive connected care strategy that addresses unique sets of market shifts and challenges permeating the HME and home infusion pharmacy industries. Last year, Brightree’s Brightree Patient Collections (BPC) solution was selected as the winner of the “Best New Technology Solution for Healthcare Payment.”
Comments